Clinical Trial Update: Combination of E-cigarettes and Varenicline for Tobacco Harm Reduction [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 trial evaluating the combination of e-cigarettes and varenicline for tobacco harm reduction and smoking cessation has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Harm Reduction
• Smoking Cessation

Drugs mentioned

• E-cigarettes (electronic cigarette)
• Varenicline (varenicline)

Snippet

Sponsor: Rose Research Center, LLC | Conditions: Smoking Cessation, Harm Reduction | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2022-02-08